Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula

While the patency of vascular access is essential for hemodialysis patients, optimal pharmaceutical treatment to maintain arteriovenous fistula (AVF) patency remains lacking. As cardiovascular diseases are highly prevalent in patients with end-stage renal disease, various cardiovascular medications...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scientific reports 2020-07, Vol.10 (1), p.12135, Article 12135
Hauptverfasser:	Chang, Te-I., Chen, Cheng-Hsien, Hsieh, Hui-Ling, Chen, Chun-You, Hsu, Shih-Chang, Cheng, Ho-Shun, Huang, Wen-Cheng, Sue, Yuh-Mou, Hsu, Yung-Ho, Lin, Feng-Yen, Shih, Chun-Ming, Lin, Shing-Jong, Huang, Po-Hsun, Liu, Chung-Te
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/409 692/700/565/1950/1544 Aged Antihypertensives Arteriovenous Fistula - diagnosis Arteriovenous Fistula - etiology Cardiovascular diseases Coronary Artery Disease - drug therapy Dipyridamole Dipyridamole - adverse effects Dipyridamole - pharmacology Dipyridamole - therapeutic use Drug Therapy, Combination End-stage renal disease Female Fistula Fistulae Hemodialysis Humanities and Social Sciences Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Kidney diseases Kidney Failure, Chronic - pathology Kidney Failure, Chronic - therapy Longitudinal Studies Male Middle Aged multidisciplinary Nitrates Nitrites Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - pharmacology Platelet Aggregation Inhibitors - therapeutic use Proportional Hazards Models Renal Dialysis Retrospective Studies Risk Factors Science Science (multidisciplinary) Statins Vascular Patency - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!